Potential clinical implications and challenges with the new obesity pharmacotherapies A new era in obesity management Tirzepatide has received FDA and EMA approval for chronic weight management and results in 20% mean WL in people without T2D
Sometimes a blood clot (thrombus) forms inside a blood vessel where it is not needed and blocks the flow of blood
Chan School of Public Health, Brigham and Women's Hospital, and Massachusetts Eye and Ear Hospital, agree that "even more expansive use of these drugs seems likely given their medical benefits and widespread popularity." "If true," they add, "our data anticipate increasing numbers of NAION cases related to this class of drugs." Further research is needed to confirm why semaglutide might increase the risk of developing NAION
When mixed with bacteriostatic water and stored properly in a refrigerator (2-8C), Melanotan 2 is stable for at least 30-45 days
A final FDA determination is expected later in 2026
Like any medication, it can have side effects, most commonly mild gastrointestinal issues